Medicine and Dentistry
Drug Megadose
100%
Cyclophosphamide
100%
Event Free Survival
100%
Pulse Rate
100%
Scleroderma
100%
Dermatosis
66%
Disease-Modifying Antirheumatic Drug
66%
Immune Reconstitution
66%
Diseases
66%
Health Assessment
33%
Immunosuppressive Treatment
33%
Gastrointestinal Disease
33%
Short Form 36
33%
Outpatient
33%
Renal Failure
33%
Myositis
33%
Hospital Inpatient
33%
Engraftment
33%
Quality of Life
33%
Stem Cell Therapy
33%
Treatment Effect
33%
Systemic Scleroderma
33%
Infectious Complication
33%
Lung Function
33%
Population Research
33%
DLCO
33%
Immunology and Microbiology
Drug Megadose
100%
Scleroderma
100%
Event Free Survival
100%
Pulse Rate
100%
Cyclophosphamide
100%
Immune Reconstitution
66%
Immunosuppressive Therapy
33%
Engraftment
33%
Systemic Scleroderma
33%
Population Research
33%
Stem Cell Transplantation
33%
Lung Function
33%
Myositis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Event Free Survival
100%
Scleroderma
100%
Skin Disease
66%
Diseases
66%
Systemic Sclerosis
33%
Population Study
33%
Kidney Failure
33%
Immunosuppressive Agent
33%
Infectious Complication
33%
Gastrointestinal Disease
33%
Myositis
33%